Gheorghiade, Mihai

Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia

Schrier, R. W., Gross, P., Gheorghiade, M., Berl, T., Verbalis, J. G., Czerwiec, F. S., & Orlandi, C. (2006) · New England Journal of Medicine

Electrolyte and hormonal disordersIon Transport and Channel Regulation

Cited by 1,215

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C.-C., & Deo, R. C. (2015) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 1,157

Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure<SUBTITLE>The EVEREST Clinical Status Trials</SUBTITLE>

Gheorghiade, M. (2007) · JAMA

Heart Failure Treatment and ManagementElectrolyte and hormonal disorders

Cited by 841

Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial

Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 605

Acute heart failure syndromes

Gheorghiade, M., & Pang, P. S. (2009) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 600

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

O'Connor, C. M., Abraham, W. T., Albert, N. M., Clare, R., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., Yancy, C. W., Young, J. B., & Fonarow, G. C. (2008) · American Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 430

The vulnerable phase after hospitalization for heart failure

Greene, S. J., Fonarow, G. C., Vaduganathan, M., Khan, S. S., Butler, J., & Gheorghiade, M. (2015) · Nature Reviews Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 406

Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure

Dei Cas, A., Khan, S. S., Butler, J., Mentz, R. J., Bonow, R. O., Avogaro, A., Tschoepe, D., Doehner, W., Greene, S. J., Senni, M., et al. (2015) · JACC Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 401

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

Pieske, B., Maggioni, A. P., Lam, C. S. P., Pieske-Kraigher, E., Filippatos, G., Butler, J., Ponikowski, P., Shah, S. J., Solomon, S. D., Scalise, A.-V., et al. (2017) · European Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 366

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G. F., Fu, M., Gheorghiade, M., Lam, C. S. P., Mehra, M. R., Neaton, J. D., Nessel, C. C., et al. (2018) · New England Journal of Medicine

Heart Failure Treatment and ManagementAtrial Fibrillation Management and Outcomes

Cited by 345

Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure

Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2008) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 257

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 231

Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial

Sarma, S., Mentz, R. J., Kwasny, M. J., Fought, A. J., Huffman, M., Subacius, H., Nodari, S., Konstam, M., Swedberg, K., Maggioni, A. P., et al. (2013) · European Journal of Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 202

Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

Greenberg, B. H., Abraham, W. T., Albert, N. M., Chiswell, K., Clare, R., Stough, W. G., Gheorghiade, M., O'Connor, C. M., Sun, J. L., Yancy, C. W., et al. (2007) · American Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 196

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

Gheorghiade, M., Fonarow, G. C., van Veldhuisen, D. J., Cleland, J. G. F., Butler, J., Epstein, A. E., Patel, K., Aban, I. B., Aronow, W. S., Anker, S. D., et al. (2013) · European Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 192

β-Blockers in Chronic Heart Failure

Gheorghiade, M., Colucci, W. S., & Swedberg, K. (2003) · Circulation

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 167

Psychological factors related to prehospital delay during acute myocardial infarction

Kenyon, L. W., Ketterer, M. W., Gheorghiade, M., & Goldstein, S. (1991) · Circulation

Acute Myocardial Infarction ResearchCardiac Health and Mental Health

Cited by 108

Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure

Gattis, W. A., O’Connor, C. M., Leimberger, J. D., Felker, G. M., Adams, K. F., & Gheorghiade, M. (2003) · The American Journal of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 80

Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes

Butler, J., Subacius, H., Vaduganathan, M., Fonarow, G. C., Ambrosy, A. P., Konstam, M. A., Maggioni, A., Mentz, R. J., Swedberg, K., Zannad, F., et al. (2013) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 60

Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies

Vaduganathan, M., Butler, J., Pitt, B., & Gheorghiade, M. (2015) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 38